Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,250 | 1,364 | 99.9% |
| Education | $24.83 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,631 | 184 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,206 | 102 | $0 (2024) |
| ABBVIE INC. | $2,024 | 141 | $0 (2024) |
| PFIZER INC. | $1,328 | 145 | $0 (2024) |
| Amgen Inc. | $1,156 | 65 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,122 | 70 | $0 (2024) |
| Lilly USA, LLC | $1,039 | 84 | $0 (2024) |
| Merck Sharp & Dohme LLC | $866.02 | 60 | $0 (2024) |
| Astellas Pharma US Inc | $688.76 | 59 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $475.81 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,687 | 218 | ABBVIE INC. ($620.01) |
| 2023 | $3,388 | 226 | Novo Nordisk Inc ($489.48) |
| 2022 | $3,340 | 243 | ABBVIE INC. ($498.39) |
| 2021 | $3,031 | 215 | Novo Nordisk Inc ($436.96) |
| 2020 | $2,181 | 160 | Novo Nordisk Inc ($465.96) |
| 2019 | $1,302 | 116 | PFIZER INC. ($229.91) |
| 2018 | $1,933 | 159 | PFIZER INC. ($347.46) |
| 2017 | $411.98 | 30 | Lilly USA, LLC ($76.34) |
All Payment Transactions
1,367 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: Cardio-renal | ||||||
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: Cardio-renal | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Biological | ||||||
| 12/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: PSYCHIATRY | ||||||
| 12/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oncology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.46 | General |
| 12/03/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Vaccines | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Obesity | ||||||
| 11/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: Biological | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $66.32 | General |
| Category: VACCINE | ||||||
| 11/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 717 | 1,083 | $82,819 | $36,899 |
| 2022 | 18 | 779 | 1,182 | $81,677 | $33,874 |
| 2021 | 16 | 722 | 886 | $75,224 | $39,045 |
| 2020 | 18 | 641 | 806 | $72,868 | $31,814 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 233 | $32,620 | $10,191 | 31.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 113 | 113 | $8,475 | $8,056 | 95.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $4,950 | $4,058 | 82.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $11,400 | $3,849 | 33.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 115 | 115 | $4,025 | $3,344 | 83.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 69 | $6,210 | $2,605 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $4,320 | $1,237 | 28.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 125 | $4,375 | $1,061 | 24.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 16 | $1,360 | $628.64 | 46.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $630.00 | $469.76 | 74.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $660.00 | $380.82 | 57.7% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 12 | 17 | $765.00 | $332.78 | 43.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 29 | $725.00 | $276.08 | 38.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 50 | 66 | $990.00 | $218.64 | 22.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 138 | $1,104 | $105.22 | 9.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 14 | 14 | $210.00 | $85.54 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 227 | $31,780 | $10,506 | 33.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 104 | 104 | $7,800 | $6,991 | 89.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 68 | 68 | $10,200 | $3,162 | 31.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 112 | 112 | $3,920 | $3,102 | 79.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 77 | $6,930 | $3,029 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 25 | $4,500 | $1,507 | 33.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 47 | 118 | $4,130 | $1,160 | 28.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 26 | 29 | $2,465 | $1,072 | 43.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 22 | 23 | $1,380 | $763.79 | 55.3% |
About Dr. Kimbra Joyce, DO
Dr. Kimbra Joyce, DO is a Family Medicine healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1033525589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kimbra Joyce, DO has received a total of $19,274 in payments from pharmaceutical and medical device companies, with $3,687 received in 2024. These payments were reported across 1,367 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($19,250).
As a Medicare-enrolled provider, Joyce has provided services to 2,859 Medicare beneficiaries, totaling 3,957 services with total Medicare billing of $141,633. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Dayton, OH
- Active Since 07/05/2014
- Last Updated 01/15/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033525589
Products in Payments
- FARXIGA (Drug) $1,483
- Ozempic (Drug) $1,244
- VRAYLAR (Drug) $891.20
- NURTEC ODT (Drug) $610.15
- QULIPTA (Drug) $600.28
- UBRELVY (Drug) $570.48
- TRADJENTA (Drug) $529.05
- JARDIANCE (Drug) $504.73
- Otezla (Drug) $477.50
- Kerendia (Drug) $475.81
- CHANTIX (Drug) $443.51
- MOUNJARO (Drug) $403.29
- Repatha (Biological) $333.59
- XARELTO (Drug) $331.81
- REXULTI (Drug) $311.54
- TRULICITY (Drug) $305.02
- XIFAXAN (Drug) $300.88
- BREZTRI (Drug) $296.29
- Wegovy (Drug) $283.64
- Cologuard Collection Kit (Device) $281.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dayton
Steve Choi, M.d, M.D
Family Medicine — Payments: $364,881
Dr. Martin Schear, Md, MD
Family Medicine — Payments: $37,153
Dr. Kwasi Nenonene, M.d, M.D
Family Medicine — Payments: $16,548
Dr. Clem Kirkland, M.d, M.D
Family Medicine — Payments: $15,511
Dr. Jeanne Kirkland, M.d, M.D
Family Medicine — Payments: $15,417
Dr. Barbara Bennett, D.o, D.O
Family Medicine — Payments: $15,125